Development Refractoriness of MLL-Rearranged Human B Cell Acute Leukemias to Reprogramming into Pluripotency

Stem Cell Reports

Volumn 7, Issue 4, 2016, Pages 602-618

  Muñoz López, Alvaro ^a   Romero Moya, Damià ^a   Prieto, Cristina ^a   Ramos Mejía, Verónica ^b   Agraz Doblas, Antonio ^a,c   Varela, Ignacio ^c   Buschbeck, Marcus ^a   Palau, Anna ^a   Carvajal Vergara, Xonia ^d   Giorgetti, Alessandra ^a   Ford, Anthony ^e   Lako, Majlinda ^f   Granada, Isabel ^a,g   Ruiz Xivillé, Neus ^a,g   Rodríguez Perales, Sandra ^h   Torres Ruíz, Raul ^a,h   Stam, Ronald W ⁱ   Fuster, Jose Luis ^j   Fraga, Mario F ^k   Nakanishi, Mahito ^l   Cazzaniga, Gianni ^m   Bardini, Michela ^m   Cobo, Isabel ^a,k   Bayon, Gustavo F ^k   Fernandez, Agustin F ^k   Bueno, Clara ^a   Menendez, Pablo ^a,n   more..

^a UNIVERSITY OF BARCELONA   (Spain)

^b PTS Granada   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d UNIVERSITY OF NAVARRA   (Spain)

^e INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^h Structural Biology and Biocomputing Programme   (Spain)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^k DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^l NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^m SAN GERARDO HOSPITAL   (Italy)

ⁿ INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

more..

Author keywords

B ALL; cancer reprogramming; DNA methylome; iPSC; MLL AF4; Sendai virus; transcriptome

Indexed keywords

1 [3 [[5 (4 AMINO 5 BROMO 7H PYRROLO[2,3 D]PYRIMIDIN 7 YL) 3,4 DIHYDROXYTETRAHYDRO 2 FURFURYL](ISOPROPYL)AMINO]PROPYL] 3 (4 TERT BUTYLPHENYL)UREA; ALKALINE PHOSPHATASE; ASCORBIC ACID; AZACITIDINE; B LYMPHOCYTE RECEPTOR; BUTYRIC ACID; DECITABINE; DNA METHYLTRANSFERASE 3B; INTERLEUKIN 3; INTERLEUKIN 7; LENTIVIRUS VECTOR; MIXED LINEAGE LEUKEMIA PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P53; RETROVIRUS VECTOR; REX PROTEIN; SALICYLATE SODIUM; SHORT HAIRPIN RNA; STAGE SPECIFIC EMBRYO ANTIGEN 3; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRA 1 60 PROTEIN; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR PAX5; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTOME; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID; BIOLOGICAL MARKER; MLL-AF4 FUSION PROTEIN, HUMAN; ONCOPROTEIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; FUSION GENE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INDUCED PLURIPOTENT STEM CELL; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PRE B LYMPHOCYTE; PRIORITY JOURNAL; SENDAI VIRUS; ANIMAL; CELL TRANSDIFFERENTIATION; CLUSTER ANALYSIS; CYTOLOGY; DNA METHYLATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETICS; METABOLISM; MYELOID PROGENITOR CELL; PHENOTYPE; TRANSFORMED CELL LINE; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; BIOMARKERS; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; CELL TRANSDIFFERENTIATION; CELLULAR REPROGRAMMING; CLUSTER ANALYSIS; DNA METHYLATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE REARRANGEMENT; HEMATOPOIETIC STEM CELLS; HETEROGRAFTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; MYELOID PROGENITOR CELLS; MYELOID-LYMPHOID LEUKEMIA PROTEIN; ONCOGENE PROTEINS, FUSION; PHENOTYPE; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR CELLS, B-LYMPHOID; TRANSCRIPTOME; TRANSLOCATION, GENETIC;

EID: 84992186929     PISSN: 22136711     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.stemcr.2016.08.013     Document Type: Article

References (55)

1. Barrett, R., Ornelas, L., Yeager, N., Mandefro, B., Sahabian, A., Lenaeus, L., Targan, S.R., Svendsen, C.N., Sareen, D., Reliable generation of induced pluripotent stem cells from human lymphoblastoid cell lines. Stem Cells Transl. Med. 3 (2014), 1429–1434.
2. Bedel, A., Pasquet, J.M., Lippert, E., Taillepierre, M., Lagarde, V., Dabernat, S., Dubus, P., Charaf, L., Beliveau, F., de Verneuil, H., et al. Variable behavior of iPSCs derived from CML patients for response to TKI and hematopoietic differentiation. PLoS One, 8, 2013, e71596.
3. Bershteyn, M., Hayashi, Y., Desachy, G., Hsiao, E.C., Sami, S., Tsang, K.M., Weiss, L.A., Kriegstein, A.R., Yamanaka, S., Wynshaw-Boris, A., Cell-autonomous correction of ring chromosomes in human induced pluripotent stem cells. Nature 507 (2014), 99–103.
4. Bibikova, M., Barnes, B., Tsan, C., Ho, V., Klotzle, B., Le, J.M., Delano, D., Zhang, L., Schroth, G.P., Gunderson, K.L., et al. High density DNA methylation array with single CpG site resolution. Genomics 98 (2011), 288–295.
5. Bollati, V., Baccarelli, A., Hou, L., Bonzini, M., Fustinoni, S., Cavallo, D., Byun, H.M., Jiang, J., Marinelli, B., Pesatori, A.C., et al. Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res. 67 (2007), 876–880.
6. Bueno, C., Montes, R., Martin, L., Prat, I., Hernandez, M.C., Orfao, A., Menendez, P., NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered?. Leukemia 22 (2008), 1475–1478.
7. Bueno, C., Catalina, P., Melen, G.J., Montes, R., Sanchez, L., Ligero, G., Garcia-Perez, J.L., Menendez, P., Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. Carcinogenesis 30 (2009), 1628–1637.
8. Bueno, C., Roldan, M., Anguita, E., Romero-Moya, D., Martin-Antonio, B., Rosu-Myles, M., del Canizo, C., Campos, F., Garcia, R., Gomez-Casares, M., et al. Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease. Haematologica 99 (2014), 1168–1175.
9. Bueno, C., van Roon, E.H., Muñoz-López, A., Sanjuan-Pla, A., Juan, M., Navarro, A., Stam, R.W., Menendez, P., Immunophenotypic analysis and quantification of B-1 and B-2 B cells during human fetal hematopoietic development. Leukemia 30 (2015), 1603–1606.
10. Bueno, C., Sardina, J.L., Di Stefano, B., Romero-Moya, D., Munoz-Lopez, A., Ariza, L., Chillon, M.C., Balanzategui, A., Castano, J., Herreros, A., et al. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPalpha. Leukemia 30 (2016), 674–682.
11. Carette, J.E., Pruszak, J., Varadarajan, M., Blomen, V.A., Gokhale, S., Camargo, F.D., Wernig, M., Jaenisch, R., Brummelkamp, T.R., Generation of iPSCs from cultured human malignant cells. Blood 115 (2010), 4039–4042.
12. Catalina, P., Montes, R., Ligero, G., Sanchez, L., de la Cueva, T., Bueno, C., Leone, P.E., Menendez, P., Human ESCs predisposition to karyotypic instability: is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties?. Mol. Cancer, 7, 2008, 76.
13. Curry, E.L., Moad, M., Robson, C.N., Heer, R., Using induced pluripotent stem cells as a tool for modelling carcinogenesis. World J. Stem Cells 7 (2015), 461–469.
14. Di Stefano, B., Sardina, J.L., van Oevelen, C., Collombet, S., Kallin, E.M., Vicent, G.P., Lu, J., Thieffry, D., Beato, M., Graf, T., C/EBPalpha poises B cells for rapid reprogramming into induced pluripotent stem cells. Nature 506 (2014), 235–239.
15. Esteban, M.A., Wang, T., Qin, B., Yang, J., Qin, D., Cai, J., Li, W., Weng, Z., Chen, J., Ni, S., et al. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6 (2010), 71–79.
16. Gandre-Babbe, S., Paluru, P., Aribeana, C., Chou, S.T., Bresolin, S., Lu, L., Sullivan, S.K., Tasian, S.K., Weng, J., Favre, H., et al. Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia. Blood 121 (2013), 4925–4929.
17. Gaspar-Maia, A., Qadeer, Z.A., Hasson, D., Ratnakumar, K., Leu, N.A., Leroy, G., Liu, S., Costanzi, C., Valle-Garcia, D., Schaniel, C., et al. MacroH2A histone variants act as a barrier upon reprogramming towards pluripotency. Nat. Commun., 4, 2013, 1565.
18. Goyal, A., Chavez, S.L., Reijo Pera, R.A., Generation of human induced pluripotent stem cells using epigenetic regulators reveals a germ cell-like identity in partially reprogrammed colonies. PLoS One, 8, 2013, e82838.
19. He, S., Malik, B., Borkin, D., Miao, H., Shukla, S., Kempinska, K., Purohit, T., Wang, J., Chen, L., Parkin, B., et al. Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner. Leukemia 30 (2016), 508–513.
20. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y.C., Laslo, P., Cheng, J.X., Murre, C., Singh, H., Glass, C.K., Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38 (2010), 576–589.
21. Hernandez-Munoz, I., Lund, A.H., van der Stoop, P., Boutsma, E., Muijrers, I., Verhoeven, E., Nusinow, D.A., Panning, B., Marahrens, Y., van Lohuizen, M., Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase. Proc. Natl. Acad. Sci. USA 102 (2005), 7635–7640.
22. Hu, K., All roads lead to induced pluripotent stem cells: the technologies of iPSC generation. Stem Cells Dev. 23 (2014), 1285–1300.
23. Irizarry, R.A., Bolstad, B.M., Collin, F., Cope, L.M., Hobbs, B., Speed, T.P., Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res., 31, 2003, e15.
24. Ji, X., Dadon, D.B., Powell, B.E., Fan, Z.P., Borges-Rivera, D., Shachar, S., Weintraub, A.S., Hnisz, D., Pegoraro, G., Lee, T.I., et al. 3D chromosome regulatory landscape of human pluripotent cells. Cell Stem Cell 18 (2016), 262–275.
25. Kumano, K., Arai, S., Hosoi, M., Taoka, K., Takayama, N., Otsu, M., Nagae, G., Ueda, K., Nakazaki, K., Kamikubo, Y., et al. Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples. Blood 119 (2012), 6234–6242.
26. Liao, J., Marumoto, T., Yamaguchi, S., Okano, S., Takeda, N., Sakamoto, C., Kawano, H., Nii, T., Miyamato, S., Nagai, Y., et al. Inhibition of PTEN tumor suppressor promotes the generation of induced pluripotent stem cells. Mol. Ther. 21 (2013), 1242–1250.
27. Lin, T., Wu, S., Reprogramming with small molecules instead of exogenous transcription factors. Stem Cells Int., 2015, 2015, 794632.
28. Marshall, A.J., Niiro, H., Yun, T.J., Clark, E.A., Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cgamma pathway. Immunol. Rev. 176 (2000), 30–46.
29. McClellan, J.S., Dove, C., Gentles, A.J., Ryan, C.E., Majeti, R., Reprogramming of primary human Philadelphia chromosome-positive B cell acute lymphoblastic leukemia cells into nonleukemic macrophages. Proc. Natl. Acad. Sci. USA 112 (2015), 4074–4079.
30. Menendez, P., Bueno, C., Wang, L., Human embryonic stem cells: a journey beyond cell replacement therapies. Cytotherapy 8 (2006), 530–541.
31. Menendez, P., Catalina, P., Rodriguez, R., Melen, G.J., Bueno, C., Arriero, M., Garcia-Sanchez, F., Lassaletta, A., Garcia-Sanz, R., Garcia-Castro, J., Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. J. Exp. Med. 206 (2009), 3131–3141.
32. Menendez, S., Camus, S., Izpisua Belmonte, J.C., p53: guardian of reprogramming. Cell Cycle 9 (2010), 3887–3891.
33. Montes, R., Ligero, G., Sanchez, L., Catalina, P., de la Cueva, T., Nieto, A., Melen, G.J., Rubio, R., Garcia-Castro, J., Bueno, C., Menendez, P., Feeder-free maintenance of hESCs in mesenchymal stem cell-conditioned media: distinct requirements for TGF-beta and IGF-II. Cell Res. 19 (2009), 698–709.
34. Montes, R., Ayllon, V., Prieto, C., Bursen, A., Prelle, C., Romero-Moya, D., Real, P.J., Navarro-Montero, O., Chillon, C., Marschalek, R., et al. Ligand-independent FLT3 activation does not cooperate with MLL-AF4 to immortalize/transform cord blood CD34+ cells. Leukemia 28 (2014), 666–674.
35. Munoz-Lopez, A., van Roon, E.H., Romero-Moya, D., Lopez-Millan, B., Stam, R.W., Colomer, D., Nakanishi, M., Bueno, C., Menendez, P., Cellular ontogeny and hierarchy influence the reprogramming efficiency of human B cells into induced pluripotent stem cells. Stem Cells 34 (2016), 581–587.
36. Nashun, B., Hill, P.W., Hajkova, P., Reprogramming of cell fate: epigenetic memory and the erasure of memories past. EMBO J. 34 (2015), 1296–1308.
37. Ohhata, T., Wutz, A., Reactivation of the inactive X chromosome in development and reprogramming. Cell Mol. Life Sci. 70 (2013), 2443–2461.
38. Onder, T.T., Kara, N., Cherry, A., Sinha, A.U., Zhu, N., Bernt, K.M., Cahan, P., Marcarci, B.O., Unternaehrer, J., Gupta, P.B., et al. Chromatin-modifying enzymes as modulators of reprogramming. Nature 483 (2012), 598–602.
39. Pasque, V., Gillich, A., Garrett, N., Gurdon, J.B., Histone variant macroH2A confers resistance to nuclear reprogramming. EMBO J. 30 (2011), 2373–2387.
40. Prieto, C., Stam, R.W., Agraz-Doblas, A., Ballerini, P., Camos, M., Castano, J., Marschalek, R., Bursen, A., Varela, I., Bueno, C., Menendez, P., Activated KRAS cooperates with MLLAF4 to promote extramedullary engraftment and migration of cord blood CD34+ HSPC but is insufficient to initiate leukemia. Cancer Res. 76 (2016), 2478–2489.
41. Ramos-Mejia, V., Bueno, C., Roldan, M., Sanchez, L., Ligero, G., Menendez, P., Martin, M., The adaptation of human embryonic stem cells to different feeder-free culture conditions is accompanied by a mitochondrial response. Stem Cells Dev. 21 (2012), 1145–1155.
42. Ramos-Mejia, V., Fernandez, A.F., Ayllon, V., Real, P.J., Bueno, C., Anderson, P., Martin, F., Fraga, M.F., Menendez, P., Maintenance of human embryonic stem cells in mesenchymal stem cell-conditioned media augments hematopoietic specification. Stem Cells Dev. 21 (2012), 1549–1558.
43. Ramos-Mejia, V., Fraga, M.F., Menendez, P., iPSCs from cancer cells: challenges and opportunities. Trends Mol. Med. 18 (2012), 245–247.
44. Ramos-Mejia, V., Montes, R., Bueno, C., Ayllon, V., Real, P.J., Rodriguez, R., Menendez, P., Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors. PLoS One, 7, 2012, e35824.
45. Ramos-Mejia, V., Navarro-Montero, O., Ayllon, V., Bueno, C., Romero, T., Real, P.J., Menendez, P., HOXA9 promotes hematopoietic commitment of human embryonic stem cells. Blood 124 (2014), 3065–3075.
46. Real, P.J., Ligero, G., Ayllon, V., Ramos-Mejia, V., Bueno, C., Gutierrez-Aranda, I., Navarro-Montero, O., Lako, M., Menendez, P., SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells. Mol. Ther. 20 (2012), 1443–1453.
47. Soria-Valles, C., Osorio, F.G., Gutierrez-Fernandez, A., De Los Angeles, A., Bueno, C., Menendez, P., Martin-Subero, J.I., Daley, G.Q., Freije, J.M., Lopez-Otin, C., NF-kappaB activation impairs somatic cell reprogramming in ageing. Nat. Cell Biol. 17 (2015), 1004–1013.
48. Srinivasan, L., Sasaki, Y., Calado, D.P., Zhang, B., Paik, J.H., DePinho, R.A., Kutok, J.L., Kearney, J.F., Otipoby, K.L., Rajewsky, K., PI3 kinase signals BCR-dependent mature B cell survival. Cell 139 (2009), 573–586.
49. Torres, R., Martin, M.C., Garcia, A., Cigudosa, J.C., Ramirez, J.C., Rodriguez-Perales, S., Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR-Cas9 system. Nat. Commun., 5, 2014, 3964.
50. Tusher, V.G., Tibshirani, R., Chu, G., Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98 (2001), 5116–5121.
51. Wu, S.M., Hochedlinger, K., Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat. Cell Biol. 13 (2011), 497–505.
52. Yamamoto, S., Otsu, M., Matsuzaka, E., Konishi, C., Takagi, H., Hanada, S., Mochizuki, S., Nakauchi, H., Imai, K., Tsuji, K., Ebihara, Y., Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1. PLoS One, 10, 2015, e0120841.
53. Ye, Z., Zhan, H., Mali, P., Dowey, S., Williams, D.M., Jang, Y.Y., Dang, C.V., Spivak, J.L., Moliterno, A.R., Cheng, L., Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 114 (2009), 5473–5480.
54. Yilmazer, A., de Lazaro, I., Taheri, H., Reprogramming cancer cells: a novel approach for cancer therapy or a tool for disease-modeling?. Cancer Lett. 369 (2015), 1–8.
55. Zhang, Z., Wu, W.S., Sodium butyrate promotes generation of human induced pluripotent stem cells through induction of the miR302/367 cluster. Stem Cells Dev. 22 (2013), 2268–2277.